Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Log in

Welcome to Biotechgate, your source for life science information.

Please use your username and password to log in to your account.

New Biotechgate version

If you already have a log in for the new Biotechgate version, click the button below to proceed.

 

No account yet?

Try Biotechgate now - learn about subscription plans and pricing!

Latest News

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program
08 Feb 2025
(GlobeNewswire)
Three-Year Results for EYLEA HD® (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals
08 Feb 2025
(GlobeNewswire)
EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting
08 Feb 2025
(GlobeNewswire)

Upcoming conferences

See Events »
Add an Event »

Latest updates

08 February 2025
Updates within the latest 30 days:
to the top ↑